Executive Director, Head of Strategy & Transformation
Regeneron Pharmaceuticals
Summary
Regeneron's Global Technology, Engineering, Operations & Application Managed Services (GTEO) runs the technology behind our research, manufacturing, and commercial operations. The Executive Director, Head of GTEO Strategy & Transformation owns strategy, planning, design, and transformation for the GTEO organization, setting multi-year direction and standards, owning the investment portfolio and budget, and leading major transformation programs through to results.
Job description
Where and When
This is an on-site position 4 days/week, primarily based at our Sleepy Hollow, NY or Warren, NJ office. Relocation benefits may be offered if eligible; a fully remote option is not available.
Discover your role
- Assist with the multi-year strategy and architectural direction for GTEO, translating enterprise priorities into a funded roadmap and setting standards that govern investment and modernization.
- Own the investment portfolio and budget end to end: prioritizing and funding against business value and capacity.
- Lead major transformation programs from strategy through delivered value, accountable for the business case and committed benefits.
- Own and shape capacity allocation so the roadmap can be funded, staffed, and sequenced.
- Set direction on technology lifecycle, refresh, and technical-debt retirement as part of the roadmap.
- Prioritize and fund transformation initiatives sourced from BPE/UX process and experience redesigns and Enterprise Architecture's technology roadmap.
- Build security and resilience into the strategy and architecture from the start, setting standards in partnership with the CISO organization.
- Set the strategy for AI adoption across GTEO, from platforms and guardrails to the operating model.
- Build and structure the transformation functions across strategy, architecture, portfolio, and operations.
- Partner with senior leaders across Research, Commercial, IOPS, and the India GCC, advising technology leadership.
- Represent the program to executive stakeholders with clear reporting, metrics, and audit-ready governance, and benchmark against industry peers.
This role might be for you if
- You have led strategy, planning, or transformation for a large infrastructure or technology organization and owned the results.
- You have built and run a technology investment portfolio, deciding what gets funded when resources are tight and demands compete.
- You have delivered large, complex transformation programs that crossed organizational lines.
- You know enough about cloud, network, compute, and platforms to set direction and standards that hold up under scrutiny.
- You understand how security and AI reshape an enterprise estate and can set strategy and standards for both while partnering with the security organization.
- You build alignment across senior stakeholders and can drive decisions without relying on direct authority.
- You have worked in pharma, biotech, or life sciences, with exposure to GxP, regulated environments, or global manufacturing.
- You have operated in a global company with central strategy and distributed delivery.
Requirements
- Bachelor's degree in information technology, Computer Science, Engineering, Information Management, or a related field
- Advanced degree (MS, MBA, or equivalent) preferred
- 15+ years in enterprise infrastructure or technology with depth in strategy, portfolio management, and transformation
- Exposure to security and AI at enterprise scale
- 5+ years leading a strategy, portfolio, or transformation function, including managing people at Director or Senior Manager level
- 3+ years owning portfolio prioritization and investment decisions in a complex, multi-domain environment
- Track record leading cross-functional programs with finance, delivery, and senior business stakeholders
- Experience in pharma, biotech, or life sciences with exposure to GxP, regulated environments, or global manufacturing
- Experience in a global company with central strategy and distributed delivery
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
- Relocation benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.